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Attention-deficit hyperactivity disorder (ADHD), 
substance use disorders, and criminality: 
a difficult problem with complex solutions
Abstract: The association between attention-deficit hyper-
activity disorder (ADHD) and criminality has been increas-
ingly recognized as an important societal concern. Studies 
conducted in different settings have revealed high rates of 
ADHD among adolescent offenders. The risk for criminal 
behavior among individuals with ADHD is increased when 
there is psychiatric comorbidity, particularly conduct dis-
order and substance use disorder. In the present report, it 
is aimed to systematically review the literature on the epi-
demiological, neurobiological, and other risk factors con-
tributing to this association, as well as the key aspects of 
the assessment, diagnosis, and treatment of ADHD among 
offenders. A systematic literature search of electronic 
databases (PubMed, EMBASE, and PsycINFO) was con-
ducted to identify potentially relevant studies published 
in English, in peer-reviewed journals. Studies conducted 
in various settings within the judicial system and in many 
different countries suggest that the rate of adolescent and 
adult inmates with ADHD far exceeds that reported in the 
general population; however, underdiagnosis is common. 
Similarly, follow-up studies of children with ADHD have 
revealed high rates of criminal behaviors, arrests, convic-
tions, and imprisonment in adolescence and adulthood. 
Assessment of ADHD and comorbid condition requires 
an ongoing and careful process. When treating offend-
ers or inmates with ADHD, who commonly present other 
comorbid psychiatric disorder complex, comprehensive 
and tailored interventions, combining pharmacological 
and psychosocial strategies are likely to be needed.
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Introduction
Attention-deficit/hyperactivity disorder (ADHD) is a 
complex and multifactorial neurodevelopmental disor-
der, with an estimated prevalence of approximately 5% 
in children and 2.5% in adults (1, 2). ADHD is character-
ized by a persistent pattern of age-inappropriate levels of 
inattention, hyperactivity, and/or impulsivity (1, 3). Along 
the lifespan, ADHD is associated with a wide range of per-
sonal, familial, medical, and social complications, with 
significant impairment in many areas of the individual 
functioning, as well as high levels of comorbid psychiat-
ric disorders (1, 4–10). Conduct disorders (CDs), including 
oppositional defiant disorder (ODD), anxiety disorders, 
and mood disorders are among the most common comor-
bid psychiatric disorders in children with ADHD, while 
mood disorders, anxiety disorders, substance use disor-
ders (SUDs), personality disorders, particularly borderline 
and antisocial personality disorders are the most common 
concurrent disorders in adult patients with ADHD.
SUDs are among the most common comorbid psychiat-
ric disorders in adolescent or adult patients with ADHD and 
vice versa (6, 11–13). While several reports have evidenced 
that ADHD is an independent risk factor for developing a 
SUD (12, 14, 15), this severe comorbidity is most likely the 
result of a complex interaction of various factors, such as 
psychiatric comorbidity, particularly CD, antisocial person-
ality disorders, and bipolar disorders (7, 16, 17). Furthermore, 
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a history of CD during childhood is the strongest predictor 
for later developing a SUD among children and adolescents 
with ADHD (17, 18).
The association between ADHD and criminality has 
been also increasingly recognized over the last decade 
and identified as an important societal concern. Indeed, a 
growing number of studies conducted in different settings 
have revealed high rates of ADHD among arrested, con-
victed, and incarcerated adolescents and adults (19–21). 
The risk for delinquent or criminal behavior among individ-
uals with ADHD is increased when there is a comorbid CD 
(22, 23). In addition, ADHD increases the risk for developing 
antisocial personality disorders and SUD in adolescence, 
which, in turn, increases the risk for criminal behavior in 
adolescence and adulthood (24). The risk for nonviolent 
and violent delinquency among adolescents or adults with 
ADHD is further increased by the coexistence of a SUD (25, 
26). Conversely, children with ADHD who exhibit high rates 
of delinquency are at risk for later developing a SUD (22).
To sum up, there seems to be a complex and not fully 
understood relationship between ADHD, comorbid SUD, 
and the emergence of delinquency and other criminal 
behaviors, particularly focusing on adolescence, and the 
importance of comorbid SUDs. Hence, gaining further 
insight about this constellation of human ailments and 
major public health problems seems warranted from a 
medical and societal perspective. In the present report, 
it is aimed to systematically review the literature on the 
epidemiological, neurobiological, and other risk factors 
contributing to this association, with a particular focus 
on adolescence. Finally, we review the key aspects of the 
assessment and diagnosis of ADHD among offenders and 
convicted individuals, as well as the treatment options for 
ADHD and whether they may affect criminality rates.
Methods
A comprehensive literature search of electronic databases (Pub-
Med, EMBASE, and PsycINFO) was conducted to identify poten-
tially  relevant studies published in English, in peer-reviewed 
journals until July 31, 2014, using the following keywords: “ADHD”, 
“ADD”, “attention deficit”, “hyperkinetic disorder”, “adolescence”, 
 “juvenile”, “ delinquency”, “offending”, “incarceration”, “crimi-
nal”, and “prison”. The literature search included clinical studies/
reports as well as retrospective or prospective population-based 
studies with children, adolescents, or adults as participants. There 
were no restrictions on the identification or inclusion of studies in 
terms of publication status, type of publication, and design type. 
However, abstracts of presentations to meetings and conferences 
were not included. Titles and abstracts were screened for inclu-
sion/exclusion and appropriateness, and full text versions were 
retrieved.
A total of 550 records were initially identified through database 
searches. After careful evaluation of the titles and abstracts, 358 
hits were considered non-eligible. Moreover, 60 of the remaining 
192 records were excluded due to the following reasons: papers in 
languages other than English (n = 8), not located in full text (n = 9), 
or not fulfilling the selection criteria (n = 43). Therefore, 132 relevant 
papers were selected from electronic databases, and two more were 
identified in their reference lists. A hand search of the major journals 
of interest retrieved 14 relevant papers, thus, 148 documents were 
finally included in this systematic review.
Epidemiology of ADHD among 
offenders
ADHD is a psychiatric condition frequently observed 
among adolescents and adults within criminal justice set-
tings. In a recent review, Young and Thome (21) reported 
that 45% of youth and 24% of adult male offenders had 
a childhood history of ADHD, and 14% continued to be 
symptomatic into adulthood. Similarly, in a large study, 
prevalence of ADHD was 18.3% of 11,603 adolescents com-
mitted to Texas juvenile correctional facilities between 
2004 and 2008 (27). Furthermore, a systematic review on 
the epidemiology of psychiatric disorders among male 
detained adolescents reported a mean ADHD prevalence 
of 13.5% (19). While ADHD prevalence has been far more 
studied among male prisoners, several studies have sug-
gested that female prisoners may have comparable high 
rates of ADHD (28–31). A systematic review and metare-
gression analysis on the prevalence of mental disorders in 
adolescents in juvenile detention and correctional facili-
ties revealed that 11.7% of boys and 18.5% of girls were 
diagnosed with ADHD (20).
As summarized in Table 1, studies conducted in adult 
offenders in diverse detention settings in France (32), Chile 
(33), USA (30, 31, 34–36), Finland (37), and Germany (38, 
39) reported very heterogeneous rates of ADHD. Similarly, 
studies with adolescent offenders conducted in Iran (40), 
Brazil (41, 43), USA (42, 46), the Netherlands (44), Denmark 
(45), and Korea (47) also showed very differing prevalence 
rates of ADHD (Table 1). Variations in prevalence rates 
among study samples may be due to differences in instru-
ments used for the assessment of ADHD, demographic 
characteristics of the samples in terms of gender and age, 
legal systems and facilities, and psychiatric comorbidities.
ADHD as a risk factor for criminality
Longitudinal, follow-up studies of children with ADHD 
have revealed high rates of criminal behaviors, arrests, 
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convictions, and imprisonment in adolescence and adult-
hood (24, 48–52), as shown in Table 2.
A childhood history of ADHD and persistence during 
adolescence and adulthood has been suggested to be a 
risk factor for the appearance of a variety of offenses (53), 
including traffic offenses (54, 55), fire setting (56), sexual 
offenses (57, 58), and property offenses (58). Persistence of 
ADHD has been described as the most powerful predictor 
of violent delinquency, even above a comorbid SUD (21).
ADHD has also been associated with an earlier onset 
of antisocial behavior and delinquency (21, 59), multiple 
serious offences (60), higher number of imprisonments 
and criminal recidivism (21, 61–64), and more breaches 
of discipline among incarcerated individuals (21, 65). 
Delinquent behavior among ADHD adolescents is a strong 
predictor for a high level of caregiver strain (66). Despite 
fewer available studies, incarcerated females with ADHD 
share important similarities in criminal behavior with 
male counterparts. They have been reported to be younger 
at first conviction, have longer periods of incarceration, 
and higher rates of psychiatric comorbidity (including 
SUD) than non-ADHD incarcerated females (38).
Impulsivity, emotional impulsiveness, mood instabil-
ity, and low self-control have been proposed as core ADHD 
symptoms predisposing to social maladjustment and 
criminal offenses (21, 67–69). In some studies, hyperactiv-
ity during childhood has been shown to be a weak predic-
tor of later criminality, whereas inattention has not been 
shown to be predictive of later criminality (70). Neverthe-
less, other authors have suggested positive correlations 
between both hyperactivity-impulsivity and inattention 
symptomatic dimensions and novelty seeking, which 
is seemingly associated with more delinquent behavior 
(67, 71, 72). In addition, childhood physical aggression 
and peer victimization among ADHD children have been 
reported to be strong predictors of delinquent behavior 
and offending during adolescence or adulthood (70, 73).
ADHD hyperactive/impulsive and combined sub-
types have been associated with higher rates of violent 
behavior, delinquency, and criminal recidivism than 
Table 1 ADHD among adolescent and adult offenders.
Reference   Sample and country   n  Instruments   ADHD prevalence
Adult samples
 Gaiffas et al. 2014 (32)   Imprisoned male adults (18–35) in France   93  CAADID   11% adult
        17% childhood
 Mundt et al. 2013 (33)   Imprisoned adults in Chilean penal institutions   1008  CIDI   2.2% adult
 Cahill et al. 2012 (30)   Imprisoned adults (17–73) in USA   3962  Coolidge   10.5% current (overall)
      Correctional   9.8% current (male)
      Inventory   15.1% current (female)
 Hennessey et al. 2010 (31)   Imprisoned female adults in USA   192  WURS   46% childhood
 Einarsson et al. 2009 (37)   Imprisoned male adults in Finland   90  MINI, WURS   50% childhood
 Westmoreland et al. 2009 (34)   Imprisoned adults in USA   319  MINI   21.3% current
 Rösler et al. 2009 (38)   Imprisoned female adults in Germany   110  HASE   24% lifetime
        10% current
 Gunter et al. 2008 (35)   Imprisoned adults in USA   320  MINI-Plus   22% lifetime
 Rösler et al. 2004 (39)   Imprisoned male adults in Germany   129  WURS   45% lifetime
 Eyestone and Howell 1994 (36)  Imprisoned male adults in US   102  Interview   25.5% current
Adolescent samples




 De Andrade et al. 2011 (41)   Imprisoned female adolescents (12–21) in Brazil  30  K-SADS-PL   33% current
 Washburn et al. 2008 (42)   Adolescents (10–18) processed in juvenile and 
adult courts in USA
  1829  DISC 2.3   8% current
 Andrade et al. 2004 (43)   Adolescents (12–19) on parole in Brazil   116  KSADS-PL   54% current
 Vreugdenhil et al. 2004 (44)   Imprisoned male adolescents (12–18) in the 
Netherlands
  204  DISC   8% current
 Gosden et al. 2003 (45)   Imprisoned adolescents (15–17) in Denmark   100  ICD-10 
diagnosis
  1% current 
(hyperkinetic disorder)
 Teplin et al. 2002 (46)   Adolescents (10–18) in a temporary detention 
center in USA
  1829  DISC 2.3   Males: 16.6% current
Females: 21.4% current
 Chae et al. 2001 (47)   Incarcerated adolescents in Korea   98  TOVA   42.4% current
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the predominantly inattentive subtype (30, 65, 74, 75). 
Although most studies only registered full syndrome 
ADHD, subthreshold ADHD may also be associated with 
higher risk of externalizing disorders, delinquent behav-
iors, younger age at first arrest, and a higher number of 
imprisonments (32, 76).
However, direct relationship between ADHD and 
offending can be difficult to estimate, as ADHD is often 
associated with comorbid disorders and other problems 
that have been independently associated with criminal 
behavior in adolescence and adulthood. Various sociode-
mographic factors such as male gender, living in an urban 
environment, low socioeconomic status, low school 
involvement, peer rejection, or high peer delinquency 
have been linked to higher rates of violence and criminal-
ity in several studies (23, 61, 77–79), while low peer delin-
quency in childhood and adolescence has been described 
as a protective factor (78). Childhood maltreatment has 
also been described as an important risk factor for delin-
quency outcomes in individuals with ADHD, regardless of 
the presence of psychiatric comorbidities (80). The impor-
tance of demographic and social risk factors in ADHD 
patients has been underlined in a longitudinal study of 
adolescent offenders in which mental health problems 
(including ADHD and SUDs) did not account for criminal 
outcomes on their own (81).
Among psychiatric disorders, CD is frequently 
comorbid to ADHD. Impulsivity appears to be the best 
predictor for the presence of CD among ADHD adoles-
cents, with minor contributions from sensation seeking 
and other ADHD symptoms (67). ADHD and CD consti-
tute a relevant association as it has been related with 
poor social functioning and the highest risk for delin-
quency outcomes (26, 58, 79, 82–84). In service sectors 
(which include the juvenile justice system), the public 
costs for adolescents with the ADHD-CD phenotype 
have been estimated to double the costs of those with 
ADHD alone (85). It has also been proposed that ADHD, 
in the absence of a comorbid CD, is not associated with 
higher rates of either criminal behavior (22, 23, 86–89) 
or recidivism (90, 91). However, several studies have 
reported that ADHD, when controlling for early aggres-
sive behavior, ODD, CD, antisocial personality disorder, 
or other psychiatric comorbidities, is still a potential risk 
factor for delinquency and criminal offences (24, 48, 71, 
84, 92–94). Gudjonsson et al. (25) recently estimated that 
ADHD contribution to the variance in nonviolent and 
violent delinquency among 11,388 young (16–24  years 
old) students was 8.2% and 8.8%, respectively, but these 
effects were almost completely mediated by the presence 
of peer delinquency and comorbidities, particularly CD 
and SUD.
ODD is another psychiatric disorder often comorbid to 
ADHD during childhood, which has also been associated 
with an earlier age of initiation into delinquent behavior, 
a greater variety of offending and higher prevalence of 
severe delinquency, though less severe than that found 
with CD (83, 84, 95, 96).
Psychopathic traits and interpersonal callousness 
are also significantly more common among adolescents 
Table 2 Criminality among ADHD patients.
Reference   Sample   n  Main findings
Dalsgaard et al. 2013 (48)   Children with ADHD attended in a psychiatric 
clinic. Reassessed in adulthood
  208  47% criminal convictions in 
adulthood
      RR for convictions = 5.6 (12 for violent 
crimes) vs. general population
Lam and Ho 2010 (49)   Children with ADHD attended in a day 
hospital.
  150  7% arrested at least once
  Reassessed in adolescence    
Langley et al. 2010 (50)   Children with ADHD treated in outpatients 
clinics.
  126  47% at least one serious criminal 
behavior
  Reassessed in adolescence     61% at least one police contact
Mannuzza et al. 2008 (24)   Children with ADHD without conduct disorder.   207  47% arrested at least once
  Reassessed in adulthood     42% convicted at least once
      15% incarcerated at least once
Satterfield and Schell 1997 (51)   Adolescents with ADHD. Reassessed in later 
adolescence and adulthood
  89  Juvenile: 46% arrested at least once
      Adults: 21% arrested at least once
Mannuzza et al. 1989 (52)   Children with ADHD. Reassessed between 
ages 16 and 23 years
  103  39% arrested at least once
      28% convicted at least once
      9% incarcerated at least once
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and adults with ADHD, and associated with serious crim-
inal behavior and recidivism (83, 91, 97, 98). Adult psy-
chopathy is heavily linked to childhood and adolescent 
history of ADHD with CD comorbidity (99, 100). Sevecke 
et  al. (101) studied risk factors for psychopathy among 
incarcerated adolescents and concluded that the influ-
ence of ADHD was largely due to an overlap with CD in 
male offenders, whereas among female offenders, ADHD 
could contribute independently to higher psychopathy 
scores.
Not only externalizing but also internalizing (mainly 
anxiety and depression) disorders have been frequently 
reported among adolescent and adult ADHD offenders 
(36, 37, 39, 99, 102). Incarcerated ADHD adults score higher 
in neuroticism and lower in agreeableness and conscious-
ness personality dimensions than non-ADHD inmates 
(103).
It is well established that ADHD patients are at high 
risk during adolescence and adulthood for SUD. The 
prevalence of SUD among imprisoned adolescents and 
adults with ADHD has been revealed to be even higher 
than in ADHD individuals from community samples (39, 
104). Moreover, among adult offenders, those with SUD 
are more likely to have a childhood history of ADHD than 
non-substance abusers (105, 106). The ADHD-SUD comor-
bidity has been reported to predispose more frequently to 
criminal offences and imprisonment than each of these 
two disorders alone (102). Aggressiveness, delinquency, 
and social impairment during childhood and adoles-
cence, as well as externalizing disorders (mainly CD, but 
also ODD), all significantly increase the risk for drug or 
alcohol use disorders in ADHD patients (107–111). On 
the other hand, parental support and knowledge about 
friendships and activities of their offsprings have been 
described to have a protective role for criminal and SUD 
outcomes among children and adolescents with ADHD 
(110, 112).
It has been proposed that in the absence of CD or 
childhood and adolescent delinquency, ADHD may not be 
associated with SUD outcomes (22, 113–115). Furthermore, 
De Sanctis et al. (116) recently reported in a 10-year follow-
up study that in the absence of maltreatment history, no 
differences were found between ADHD patients and con-
trols in rates of criminal behaviors and SUD. However, 
Thompson et al. (117) reported that boys with the CD-ADHD 
comorbidity had more substance dependence diagnoses 
than boys with CD alone.
Comorbidity between ADHD, CD, and SUDs is highly 
relevant as it has been associated with worse functional 
impairment (118), increased rates of suicidal behavior 
(119), as well as higher risk for other psychiatric disorders, 
such as depression (117), anxiety (117), posttraumatic 
stress disorder (120, 121), eating disorders (38), borderline 
personality disorder (38), or abnormal sleep architecture 
(122).
Neurobiological substrates of ADHD 
and criminality
The precise underlying etio-physiology of ADHD remains 
unknown, but molecular genetic studies have revealed 
that genes play a key role, with heritability about 75–80% 
(123, 124). ADHD is, however, a polygenic disorder with at 
least 50 genes involved (125), which may explain the clini-
cal heterogeneity of ADHD presentations and comorbidity 
with other psychiatric disorders, including CD and antiso-
cial personality (126, 127).
Three specific genes have been implicated in ADHD 
with concurrent antisocial behavior and delinquency, 
three genes have shown to be most related: the gene 
coding the dopamine receptor D4 (DRD4), the dopa-
mine transporter (DAT1), and the serotonin transporter 
(5-HTT) (124, 128). However, penetrance for studied 
polymorphisms of all three genes is low, which means 
many carriers will not develop the disorder (126). A gene 
× gene interaction between DRD2 and DRD4 has been 
linked to the appearance of CD and antisocial behavior 
in males (129). Similarly, an association between various 
DRD4 poly morphisms and ADHD susceptibility has been 
reported, while both DRD4-7 repeat allele and DAT1-10 
repeat allele have been related with hazardous sensation 
seeking, antisocial behavior, and offenses (126, 130–133). 
Conversely, a protective effect against risky behaviors has 
been reported with the 9R/9R genotype in the VNTR of the 
dopamine transporter gene (DAT1), in comparison to the 
10R/9R and 10R/10R genotypes. However, this protective 
effect seems to vary over age (134). The long variant (espe-
cially the homozygous L/L genotype) of the serotonin 
transporter promoter region (5-HTTLPR), has been related 
with a higher risk for ADHD and a decreased behavior-
inhibiting capability (135).
Despite the importance of genetic factors, 20% of 
the variance of ADHD symptoms is due to environmental 
factors (126). Among these, prenatal exposure to mari-
juana or lead has been related to ADHD symptoms and 
increased criminal behaviors (136, 137).
Neuroimaging studies have evidenced that ADHD 
patients present low prefrontal cortex activation while 
trying to modulate attention and behavior (138). Pre-
frontal cortex seems to have an integrative function and 
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plays an essential role in social cognition, so its malfunc-
tion could hypothetically favor antisocial behavior (139). 
Additionally, some authors have reported hyporeactivity 
of the autonomic nervous system (ANS) among ADHD 
individuals, especially when comorbidity with CD or ODD 
is present (140, 141). An unresponsive ANS involves a low 
level of fear and has been associated to delinquent behav-
ior (142).
Evaluation of ADHD and comorbid 
conditions
In spite of the high prevalence and comorbidity of ADHD, 
CD, and SUD among adolescent and adult offenders, 
underdiagnosis is still common across different settings 
of the justice system (143). Furthermore, in a recent study 
conducted in an outpatient clinic for forensic mental 
health care, ADHD diagnosis was missed previously in life 
more than half (56%) of adults patients who have prob-
lems with delinquency (144). Older men, individuals with 
hyperactive/impulsive and combined subtypes of ADHD, 
patients who reported fewer symptoms of ADHD in child-
hood or adolescence, those with a comorbid mood disor-
der in adulthood, and in those who had never received 
mental health care before, were more likely not to have 
been previously diagnosed with ADHD. Considering that 
ADHD may be missed very often in individuals with a 
criminal history, the importance of routine screening of 
ADHD and psychiatric comorbidities within offender and 
forensic management services is clearly warranted (143).
Adequate evaluation of symptoms of ADHD must be 
conducted under a biopsychosocial clinical perspective 
and necessarily must include assessment of family func-
tioning style. In addition, the assessment process should 
comprise general personality characteristics and specifi-
cally antisocial traits, comorbid SUD, as well as external-
izing disorders (CD, ODD) and internalizing disorders 
(depression, anxiety, eating disorders) (145).
Self-report questionnaires may be useful for ADHD 
screening, due to their rapid implementation and high 
cost effectiveness (146). The Wender Utah Rating Scale 
(WURS) has shown to be useful for evaluation of child-
hood ADHD symptoms in several epidemiologic studies 
(31, 37, 39). The Coolidge Correctional Inventory (CCI) is 
a 250-item, self-report, DSM-IV criteria-based inventory, 
specifically designed for incarcerated population over 
15  years old, with good psychometric properties (147). 
Several authors have warned about low reliability of 
self-report instruments, as offenders with mental health 
disorders tend to minimize symptoms (148, 149). More-
over, ADHD offenders have shown to be less reliable than 
controls in self-reporting delinquent acts (150). Thus, 
parental information about lifetime ADHD, symptoms of 
CD, and criminal behavior should always be obtained, 
whenever possible.
Some structured diagnostic interviews, which can 
be administered by nonclinical interviewers after a short 
training period, have also shown to be useful in the assess-
ment of ADHD. The National Institute of Mental Health 
Diagnostic Interview Schedule for Children (NIMH DISC) 
for children and adolescents (151) and the MINI Inter-
national Neuropsychiatric Interview (MINI) for adults 
(152) have been frequently used in epidemiologic studies 
among criminal offenders (34, 35, 37, 42, 44, 46).
Treatment of ADHD and criminal 
behaviors
Treatment programs, including medication and psy-
chosocial interventions, can be very effective in improv-
ing the functioning of children, adolescents, and adults 
with ADHD in a broad range of functional outcomes (8, 
153). Treatment guidelines recommend pharmacological 
treatments as the first line for children, adolescents, and 
adults with severe ADHD, but always within a compre-
hensive treatment program that addresses psychological, 
behavioral, and educational or occupational needs (8, 
154). Nonetheless, there are few studies on effective inter-
ventions for children and adolescents with delinquent or 
violent behaviors.
Overall, treatment guidelines recommend treatment 
with medication as the first line for children, adolescent, 
and adults with severe ADHD and psychological treat-
ment as the first line for those with less severe symptoms 
(8, 153, 155). Furthermore, in a comprehensive systematic 
review, it was concluded that there was consistent evi-
dence that pharmacotherapies are cost effective compared 
with no treatment or behavioral therapy for children and 
adolescents with ADHD (156). In addition, as shown in 
recent study using a large sample of 25,656 patients with a 
diagnosis of ADHD in Sweden, criminality rates were sig-
nificantly lower for both men and women during periods 
when they were receiving ADHD medication (157).
A large number of randomized, controlled studies 
conducted in children, adolescents, and adults with 
ADHD and with or without other comorbid conditions 
have shown the efficacy and effectiveness of stimulant 
and nonstimulant medication on a variety of outcome 
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variables (6, 153, 154, 158–162). However, medication 
alone is unlikely to achieve these aims fully. Furthermore, 
the net effect of medications on criminality remains to 
be established. While pharmacological treatment may 
have a protective effect on concurrent rates of all types of 
criminality, there appears to be no significant long-term 
reduction in crime rate after termination of medication 
(157, 163). Another aspect that should be considered in the 
treatment of ADHD offenders is the potential of abuse and 
risk of misuse of pharmacotherapies used in the treatment 
of ADHD, particularly in individuals with comorbid SUD. 
Short-acting stimulants should be avoided, and long-
acting stimulant formulation should be prescribed with 
caution to patients at risk of stimulant misuse or diver-
sion and in those with particular concern for medication 
abuse, and atomoxetine or other non-stimulant medica-
tions, whenever available, may be considered as first-line 
pharmacotherapies for ADHD (8).
Antipsychotics have also been considered as a treat-
ment for children and adolescent ADHD and comorbid 
conduct disorder. Indeed, risperidone may be useful for 
adolescents with refractory and persistent symptoms of 
ADHD and ODD (109), as well as in children and adoles-
cents with ADHD, ODD, and severe conduct disorder (164). 
In a further open-label study, another atypical antipsy-
chotic, aripiprazole, was well-tolerated and associated 
with significant improvements in symptoms of inatten-
tion, hyperactivity/impulsivity, as well as of ODD and 
conduct disorder (165). In addition, aripiprazole was also 
associated with significant improvements in delinquent 
and aggressive behavior. The potential beneficial effects 
of these medications, used off license, need to be assessed 
in randomized-controlled trials.
When treating offenders or inmates with ADHD, who 
commonly present other comorbid psychiatric disorder 
complexes, comprehensive and tailored interventions 
are likely to be needed. Multiple psychological and psy-
chosocial interventions have been used to manage the 
symptoms and problems experienced by patients diag-
nosed with ADHD. However, few studies have systemati-
cally evaluated the efficacy of psychosocial treatments in 
adolescents and adults with ADHD and severe disruptive 
behavioral problems. In a recent systematic review, behav-
ioral interventions for children and adolescents diag-
nosed with ADHD were found to have significant positive 
effects on a range of other outcomes, including conduct 
problems, social skills, and academic performance (166). 
Indeed, the Stop Now and Plan (SNAP) Program, an inter-
vention for boys aged 6–11  years with severe aggressive, 
rule-breaking, or antisocial behavior, was assessed in a 
randomized controlled treatment effectiveness study vs. 
standard behavioral treatment (167). Participants in the 
SNAP intervention showed significantly greater reduc-
tion in aggression, conduct problems, and overall exter-
nalizing behavior, as well as on symptoms of depression, 
anxiety, ODD, and ADHD. Furthermore, the beneficial 
effects of the SNAP program on aggression, ODD, and 
ADHD persisted at 1-year follow-up. Another home-based 
cognitive behavioral prevention program, targeting first-
time delinquent children aged 8–13 years with ADHD and 
concurrent conduct disorder, was reported to be effective 
in reducing problem behavior (168). Likewise, the effec-
tiveness of the Reasoning and Rehabilitation for ADHD 
Youths and Adults (R&R2ADHD) cognitive behavioral 
group treatment was assessed in another randomized 
controlled study (169). After treatment and at 3-month 
follow-up, this CBT program increased the effect of 
psychopharmacological treatment in reducing ADHD 
symptoms and comorbid problems, including antisocial 
behavior and social functioning.
Finally, another aspect that needs to be addressed by 
clinicians and treatment planners and researchers is the 
adequate health care transition for adolescents and young 
adults with ADHD, considering that discontinuity in the 
transition from pediatric to adult health care for ADHD 
patients has also been linked to higher rates of criminality 
(170). Moreover, one prominent feature of ADHD treatment 
is that the discontinuation of medication is common espe-
cially in adolescence and early adulthood (171, 172). This 
is of particular importance in adolescents and younger 
adults with severely disruptive or criminal behaviors, who 
are likely to have more severe and pervasive symptoms of 
ADHD, and less likely to adhere or comply to treatment 
(173). Furthermore, although importance of treatment 
discontinuation for criminality and other longer-term out-
comes is largely unknown (157), it may increase the risk to 
fall into a “revolving door” between prison and probation, 
and the community (8).
Conclusions
As evidenced by epidemiological and neurobiological 
studies, ADHD, mainly in combination with other psy-
chiatric disorders, particularly ODD, conduct disorders, 
SUD, and antisocial personality disorders, has been 
identified as an important risk factor for criminal and 
delinquent behaviors and offending, with an early onset 
of criminal behavior and high rates of recidivism among 
young individuals (21, 26, 39, 174). Furthermore, the com-
bination of ADHD with other comorbid disorders during 
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childhood and adolescence is significantly related to a 
range of environmental factors, including an earlier initia-
tion to substance use and a more severe SUD, which may 
further increase the risk for criminal offending (17, 19). It 
is, therefore, very important to carefully and systemati-
cally assess for the presence of ADHD in adolescents and 
adults within juvenile and adult correctional and forensic 
services, as well as among offenders and prison inmates. 
Pharmacological and psychosocial treatment programs 
for adolescents and adult offenders with ADHD are very 
limited in many countries, particularly within prisons 
and other detention facilities (143). Although there is no 
conclusive evidence that such treatments lower the risk 
for developing delinquency in adulthood, several com-
prehensive and integral treatment programs have been 
shown to be effective in reducing aggressive, violent, or 
other severely disruptive behaviors (8, 109, 167, 169). It 
is, therefore, important to provide adequate treatment to 
adolescent or adult offenders, particularly to those previ-
ously not diagnosed or treated, considering that ADHD 
among incarcerated individuals is likely to be associated 
with high recidivism rates and with substantial higher 
economic and societal costs than their non-ADD coun-
terparts (8, 143). Therefore, any strategy toward reduc-
ing future offending and detention, addressing known 
vulnerability factors such as ADHD and other comorbid 
disorders, should be a priority for clinicians, researchers, 
and policymakers.
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